<DOC>
	<DOCNO>NCT02388386</DOCNO>
	<brief_summary>The investigator aim develop novel wireless method monitor medication adherence among heart failure patient leave ventricular assist device ( LVADs ) . Proteus Digital™ develop ingestible bio-absorbable micro-sensor strategy monitor medication compliance . The edible sensor core silicon-based integrated circuit measure 1.0 mm x 0.45 mm imbed pill . Once ingested , circuit activate gastric acid result electrochemical redox reaction electrical charge transmit patch worn abdomen wirelessly portable device smart phone . This strategy medication adherence differs conventional adherence monitoring include pill count patient-recall precisely track medication ingestion .</brief_summary>
	<brief_title>Monitoring Medication Adherence Left Ventricular Assist Device Recipients</brief_title>
	<detailed_description>The objective assess efficacy safety Proteus Digital™ micro-sensor exploratory investigation among heart failure patient LVADs . Medication adherence , specifically anticoagulation critically important post-implant period maintain LVAD function decrease thromboembolic complication ; however , commonly result significant bleed result significant morbidity mortality . In addition , anticipate degree anticoagulation unpredictable LVAD implantation due factor related change hepatic blood flow endothelial dysfunction . Enrolling 10 patient provide result function micro-sensor provide preliminary assessment sensor-based activity , signal strength signal duration LVAD recipient . Participants enrol in-patient hospitalization ass efficacy safety device monitor setting .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients undergo LVAD implantation endstage heart failure admit outpatient set Unable consistently consume oral intake Hemodynamic instability define hypotension require intravenous vasoactive medication arrhythmias require intravenous antiarrhythmic oral antiarrhythmic rhythm stabilization Gastrointestinal bleeding require intravenous gastric acid secretion inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Telemedicine</keyword>
	<keyword>Mobile Health</keyword>
</DOC>